NewYork-Presbyterian/Columbia University Irving Medical Center is leading a global phase 1-3 clinical trial of an experimental drug – jacifusen – that may alter the progression of amyotrophic lateral sclerosis.
Neurology
Major Grant Propels Research in Early Stage Parkinson’s Disease
Weill Cornell Medicine neuroscience team to study how abnormal protein aggregates may spread from the gut to the brain to drive the early stages of Parkinson’s disease.